Efficacy, Immunogenicity and Safety of V503 in Chinese Women Aged 20-45 Years (V503-023)

Clinical trial NCT03998254 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03998254
Sponsor: Merck Sharp & Dohme LLC
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Papillomavirus Infections

Start date: 2019-06-26
Primary completion: 2028-03-31
Enrollment: 6000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.